Suven Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company will be held on June 08, 2021, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and for the year ending March 31, 2021; and to consider and recommend a final dividend, if any, for the financial year ending March 31, 2021. Further note that trading window for dealing in the securities of the Company is already closed from April 01, 2021 as per PIT Code of the Company. Trading window will be opened from June 11, 2021.
The above information is a part of company’s filings submitted to BSE.
